Kala Pharmaceuticals (KALA) Stock Highlights

5.92 | -1.33%

2024-12-21 07:19:40

Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the discovery, development and commercialization of innovative therapies for diseases of the eye. The companys two marketed products are EYSUVIS and INVELTYS.

Statistics

Range Today

5.75 6.04

Volume Today 12.9K

Range 1 Year

4.21 9.25

Volume 1 Year 19.64M

Range 3 Year

3.54 97

Volume 3 Year 230.36M

Range 10 Year

3.54 1337.5

Volume 10 Year 249.34M

Highlights

Market Capitalization 41.82M (micro)

Floating Shares 2.79M

Current Price 5.92

Price To Earnings -0.46

Price To Book 2.56

Earnings Per Share -14.96

Payout Ratio 0%

Performance

Latest -1.33%

1 Month -6.77%

3 Months +2.6%

6 Months +13.85%

1 Year -12.43%

3 Years -91.29%

5 Years -97.11%

10 Years -99.29%

Benchmarks

Market Capitalization

330 / 368

Gross Profits

125 / 278

Total Revenue

288 / 300

Total Rank

171 / 368

Free Cashflow

140 / 352

Performance 5 years

339 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.